Avigan

Denka Begins Producing Raw Materials for Avigan as Effort Against Novel Coronavirus

Denka Co. Ltd. (TYO:4061) recently began production of diethyl malonate for use in Avigan, a potential COVID-19 treatment known also by the generic name of favipiravir. This production began on May 16 at the chemical company and chloroprene rubber producer’s Omi Plant in Itoigawa, Niigata Prefecture. Denka sees itself as having a social responsibility to help out with measures against...

Please subscribe to read the full story.Subscribe
Already a member? Log in here
Continue Reading

Denka to Supply Raw Materials for Potential COVID-19 Treatment Avigan

Denka Co. Ltd. (TYO:4061) recently announced that it has decided to supply diethyl malonate, a raw material for anti-flu drug Avigan, in response to a request from the Japanese government. Also known as favipiravir, Avigan is being touted as a potential treatment for COVID-19 patients. This diethyl malonate production is slated to start in May at Denka’s Omi Plant in...

Please subscribe to read the full story.Subscribe
Already a member? Log in here
Continue Reading